Director's Dealing • Feb 3, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
News Details
Directors’ Dealings | 3 February 2022 13:54
DGAP-DD: Siemens Healthineers AG english
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
03.02.2022 / 13:53
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
| Title: | |
| First name: | Elisabeth |
| Last name(s): | Staudinger-Leibrecht |
2. Reason for the notification
a) Position / status
| Position: | Member of the managing body |
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Siemens Healthineers AG
b) LEI
529900QBVWXMWANH7H45
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
| Type: | Share |
| ISIN: | DE000SHL1006 |
b) Nature of the transaction
| Entitlement to transfer 581 Siemens Healthineers shares without consideration in connection with a Siemens Healthineers Stock Program (transfer with value date 2022-02-24, +1:00). |
| Transaction linked to the exercise of share option programmes |
c) Price(s) and volume(s)
| Price(s) | Volume(s) |
| not numberable | not numberable |
d) Aggregated information
| Price | Aggregated volume |
| not numberable | not numberable |
e) Date of the transaction
2022-02-01; UTC+1
f) Place of the transaction
Outside a trading venue
03.02.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Siemens Healthineers AG |
| Henkestr. 127 | |
| 91052 Erlangen | |
| Germany | |
| Internet: | https://www.siemens-healthineers.com |
| End of News | DGAP News Service |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.